Rare diseases
Investigational molecules
Locations
Back to Czechia39 clinical trials in Jindřichův Hradec, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
CzechiaCzechiaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older
CzechiaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma
CzechiaStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
CzechiaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
CzechiaStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
CzechiaComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on chronic obstructive pulmonary disease (COPD) and asthma management, investigating new therapeutic approaches and treatment combinations for patients with moderate to severe conditions.
Current trials are evaluating novel medications like tezepelumab and itepekimab for improving patient outcomes.
Research focusing on vaccine development for infectious diseases, including studies on chickenpox and meningococcal vaccines for different age groups.
Clinical trials are assessing immune responses and safety profiles in children and infants.
Investigation of treatments for bronchiectasis and respiratory syncytial virus (RSV), with emphasis on developing targeted therapies for specific patient populations.
Innovative approaches are being tested to address acute and chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
